(Circulation. 2001;103:1799.)
© 2001 American Heart Association, Inc.
Basic Science Reports |
Anti-Inflammatory, Antithrombotic, and Neuroprotective Effects of Activated Protein C in a Murine Model of Focal Ischemic Stroke
From the Department of Neurosurgery (M.S., S.R.K., A.A.) and the Department of Pathology (F.H.), University of Southern California, Los Angeles; the Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla (J.A.F., J.H.G.), Calif; and the Division of Neurovascular Biology and the Department of Neurosurgery, Center for Aging and Developmental Biology, University of Rochester Medical Center (B.V.Z.), Rochester, NY.
Correspondence to Berislav V. Zlokovic, MD, PhD, Arthur Kornberg Medical Research Bldg, 601 Elmwood Ave, Box 645, Rochester, NY 14642. E-mail berislav_zlokovic{at}urmc.rochester.edu
Background—Activated protein C (APC) contributes to systemic anticoagulant and anti-inflammatory activities. APC may reduce organ damage by inhibiting thrombin generation and leukocyte activation. Neutrophils and cerebrovascular thrombosis contribute to ischemic neuronal injury, suggesting that APC may be a potential protective agent for stroke.
Methods and Results—We examined the effects of APC in a murine model of focal ischemia. After middle cerebral artery occlusion/reperfusion, the average survival time in controls was 13.6 hours. Animals that received purified human plasma–derived APC 2 mg/kg IV either 15 minutes before or 10 minutes after stroke induction survived 24 hours and were killed for neuropathological analysis. APC 2 mg/kg given before or after onset of ischemia restored cerebral blood flow, reduced brain infarct volume (59% to 69%; P<0.003) and brain edema (50% to 61%; P<0.05), eliminated brain infiltration with neutrophils, and reduced the number of fibrin-positive cerebral vessels by 57% (P<0.05) and 25% (nonsignificant), respectively. The neuroprotective effect of APC was dose-dependent and associated with significant inhibition of ICAM-1 expression on ischemic cerebral blood vessels (eg, 61% inhibition with 2 mg/kg APC). Intracerebral bleeding was not observed with APC.
Conclusions—APC exerts anti-inflammatory, antithrombotic, and neuroprotective effects in stroke. Central effects of APC are likely to be related to improved maintenance of the blood-brain barrier to neutrophils and to reduced microvascular obstructions and fibrin deposition.
Key Words: proteins • ischemia • blood cells • cerebrovascular disorders • thrombosis • nervous system
This article has been cited by other articles:
 |
|
 |
|
  J.-S. Bae, L. Yang, C. Manithody, and A. R. Rezaie The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells Blood, December 1, 2007; 110(12): 3909 - 3916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. O. Mosnier, B. V. Zlokovic, and J. H. Griffin The cytoprotective protein C pathway Blood, April 15, 2007; 109(8): 3161 - 3172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Raivio, J. A. Fernandez, A. Kuitunen, J. H. Griffin, R. Lassila, and J. Petaja Activation of protein C and hemodynamic recovery after coronary artery bypass surgery J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 44 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Alsfasser, A. L. Warshaw, S. P. Thayer, B. Antoniu, M. Laposata, K. B. Lewandrowski, and C. Fernandez-del Castillo Decreased Inflammation and Improved Survival With Recombinant Human Activated Protein C Treatment in Experimental Acute Pancreatitis Arch Surg, July 1, 2006; 141(7): 670 - 676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yamauchi, M. Sakurai, K. Abe, H. Takano, and Y. Sawa Neuroprotective Effects of Activated Protein C Through Induction of Insulin-Like Growth Factor-1 (IGF-1), IGF-1 Receptor, and Its Downstream Signal Phosphorylated Serine-Threonine Kinase After Spinal Cord Ischemia in Rabbits Stroke, April 1, 2006; 37(4): 1081 - 1086. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Dahlback and B. O. Villoutreix Regulation of Blood Coagulation by the Protein C Anticoagulant Pathway: Novel Insights Into Structure-Function Relationships and Molecular Recognition Arterioscler. Thromb. Vasc. Biol., July 1, 2005; 25(7): 1311 - 1320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Nicole, A. Goldshmidt, C. E. Hamill, S. D. Sorensen, A. Sastre, P. Lyuboslavsky, J. R. Hepler, R. J. McKeon, and S. F. Traynelis Activation of Protease-Activated Receptor-1 Triggers Astrogliosis after Brain Injury J. Neurosci., April 27, 2005; 25(17): 4319 - 4329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Ludeman, H. Kataoka, Y. Srinivasan, N. L. Esmon, C. T. Esmon, and S. R. Coughlin PAR1 Cleavage and Signaling in Response to Activated Protein C and Thrombin J. Biol. Chem., April 1, 2005; 280(13): 13122 - 13128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C. Y. Liaw, C. T. Esmon, K. Kahnamoui, S. Schmidt, S. Kahnamoui, G. Ferrell, S. Beaudin, J. A. Julian, J. I. Weitz, M. Crowther, et al. Patients with severe sepsis vary markedly in their ability to generate activated protein C Blood, December 15, 2004; 104(13): 3958 - 3964. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Contreras, C. Eckstein, C. A. Smyth, G. Bilbao, M. Vilatoba, S. E. Ringland, C. Young, J. A. Thompson, J. A. Fernandez, J. H. Griffin, et al. Activated Protein C Preserves Functional Islet Mass After Intraportal Transplantation: A Novel Link Between Endothelial Cell Activation, Thrombosis, Inflammation, and Islet Cell Death Diabetes, November 1, 2004; 53(11): 2804 - 2814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Olivot, J. Labreuche, M. Aiach, P. Amarenco, and for the GENIC Investigators Soluble Thrombomodulin and Brain Infarction: Case-Control and Prospective Study Stroke, August 1, 2004; 35(8): 1946 - 1951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Sakamoto, H. Ogawa, K. Takazoe, M. Yoshimura, H. Shimomura, Y. Moriyama, H. Arai, and K. Okajima Effect of activated protein C on plasma plasminogen activator inhibitor activity in patients with acute myocardial infarction treated with alteplase: Comparison with unfractionated heparin J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1389 - 1394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Niessen, T. Hilger, M. Hoehn, and K.-A. Hossmann Differences in Clot Preparation Determine Outcome of Recombinant Tissue Plasminogen Activator Treatment in Experimental Thromboembolic Stroke Stroke, August 1, 2003; 34(8): 2019 - 2024. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Domotor, O. Benzakour, J. H. Griffin, D. Yule, K. Fukudome, and B. V. Zlokovic Activated protein C alters cytosolic calcium flux in human brain endothelium via binding to endothelial protein C receptor and activation of protease activated receptor-1 Blood, June 15, 2003; 101(12): 4797 - 4801. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Liu, H. Guo, J. H. Griffin, J. A. Fernandez, and B. V. Zlokovic Protein S Confers Neuronal Protection During Ischemic/Hypoxic Injury in Mice Circulation, April 8, 2003; 107(13): 1791 - 1796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Hafer-Macko, F. M. Ivey, K. A. Gyure, J. D. Sorkin, and R. F. Macko Thrombomodulin Deficiency in Human Diabetic Nerve Microvasculature Diabetes, June 1, 2002; 51(6): 1957 - 1963. [Abstract] [Full Text] [PDF]
|
|